COMP <GO>
WRBY vs UNH // GROSS PROFIT MARGIN
Warby Parker Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: WRBY 4
— UNH 10
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $24.61 (+0.08%) • MKT CAP: $3.04B
gross-margins
54.00%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WRBY VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WRBY | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 54.00% | 88.57% | -34.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.70% | 11.47% | -13.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.44% | 6.48% | -5.04 | UNH | /fcf-yield <GO> |
| Operating Margin | -0.60% | 4.82% | -5.42 | UNH | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 3.14% | -2.94 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 6.46% | +6.54 | WRBY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.35 | 3.12 | +2.23 | WRBY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | WRBY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.74% | +0.66 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 56.0 | -10.12 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.14 | 0.33 | +0.81 | WRBY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 17.1x | +122.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $364.66B | -$361.62B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WRBY REV | UNH REV | WRBY GROSS % | UNH GROSS % | WRBY FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $871.9M | $447.57B | 54.0% | 88.7% | $43.7M | $16.07B |
| FY 2024 | $771.3M | $400.28B | 55.3% | 88.3% | $34.7M | $20.70B |
| FY 2023 | $669.8M | $371.62B | 44.0% | 89.6% | $30.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WRBY // BETA 1.14
UNH // BETA 0.33